Eton Pharmaceuticals (ETON) Shareholder's Equity Growth (1y) (2018 - 2025)
Eton Pharmaceuticals (ETON) Shareholder's Equity Growth (1y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Eton Pharmaceuticals | 806.97 Mn | 781.03 Mn | 13.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.07% |
| Sep 30, 2025 | 44.71% |
| Jun 30, 2025 | 77.99% |
| Mar 31, 2025 | 57.80% |
| Dec 31, 2024 | 57.83% |
| Sep 30, 2024 | -5.39% |
| Jun 30, 2024 | -19.51% |
| Mar 31, 2024 | 37.83% |
| Dec 31, 2023 | 18.34% |
| Sep 30, 2023 | 51.08% |
| Jun 30, 2023 | 26.30% |
| Mar 31, 2023 | -16.01% |
| Dec 31, 2022 | -25.82% |
| Sep 30, 2022 | -28.60% |
| Jun 30, 2022 | -36.14% |
| Mar 31, 2022 | -37.91% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | 1,028.24% |
| Jun 30, 2021 | 194.92% |
| Mar 31, 2021 | 102.97% |